Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma

被引：65

作者：

Hoffman, Seth A. ^{[1
]}

Joo, Won-A. ^{[1
]}

Echan, Lynn A. ^{[1
]}

Speicher, David W. ^{[1
]}

机构：

[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA

来源：

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 849卷 / 1-2期

关键词：

cancer; proteomics; plasma proteome; serum proteome; blood proteome; multidimensional separation; biomarkers; protein separation; peptide separation;

D O I：

10.1016/j.jchromb.2006.10.069

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The plasma proteome has a wide dynamic range of protein concentrations and is dominated by a few highly abundant proteins. Discovery of novel cancer biomarkers using proteomics is particularly challenging because specific biomarkers are expected to be low abundance proteins with normal blood concentrations of low nanograms per milliliter or less. Conventional, one- and two-dimensional proteomic methods including 2D PAGE, 2D DIGE, LC-MS/MS, and LC/LC-MS/MS do not have the capacity to consistently detect many proteins in this range. In contrast, new higher dimensional (Hi-D) separation strategies, utilizing more than two dimensions of fractionation, can profile the low abundance proteome. (c) 2006 Elsevier B.V. All rights reserved.

引用

页码：43 / 52

页数：10

共 54 条

[1] Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project [J].

Adamski, M ;

Blackwell, T ;

Menon, R ;

Martens, L ;

Hermjakob, H ;

Taylor, C ;

Omenn, GS ;

States, DJ .

PROTEOMICS, 2005, 5 (13) :3246-3261

[2] Toward a human blood serum proteome - Analysis by multidimensional separation coupled with mass spectrometry [J].

Adkins, JN ;

Varnum, SM ;

Auberry, KJ ;

Moore, RJ ;

Angell, NH ;

Smith, RD ;

Springer, DL ;

Pounds, JG .

MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (12) :947-955

[3] The use of proteomics for the assessment of clinical samples in research [J].

Aldred, S ;

Grant, MM ;

Griffiths, HR .

CLINICAL BIOCHEMISTRY, 2004, 37 (11) :943-952

[4]

ALFTHAN H, 1992, CLIN CHEM, V38, P1981

[5]

ANDERSON JL, 2004, MOL CELL PROTEOMICS, P311

[6] Candidate-based proteomics in the search for biomarkers of cardiovascular disease [J].

Anderson, L .

JOURNAL OF PHYSIOLOGY-LONDON, 2005, 563 (01) :23-60

[7] The human plasma proteome - History, character, and diagnostic prospects [J].

Anderson, NL ;

Anderson, NG .

MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867

[8]

Bidart JM, 1999, CLIN CHEM, V45, P1695

[9] Metabolic response to injury and sepsis: Changes in protein metabolism [J].

Biolo, G ;

Toigo, G ;

Ciocchi, B ;

Situlin, R ;

Iscra, F ;

Gullo, A ;

Guarnieri, G .

NUTRITION, 1997, 13 (09) :S52-S57

[10]

BRIO L, 1998, EUR J CLIN INVEST, P679

← 1 2 3 4 5 6 →